PHOTO
Abu Dhabi: Mediclinic Airport Road Hospital is the first private hospital in Abu Dhabi to achieve the prestigious Clinical Care Program Certification by the Joint Commission International for its Acute Coronary Syndrome (ACS) Program. The program specialises in the management of patients suffering from various types of heart attacks and coronary artery disease.
Joe Hazel, Chief Operating Officer of Mediclinic in Abu Dhabi, said in a statement: “This achievement is testament to the excellence of our cardiac care service that is practised to the highest of international standards. We are proud to say that our Acute Coronary Syndrome (ACS) program at Mediclinic Airport Road Hospital underwent a rigorous certification process by US-based Joint Commission International (JCI) by successfully fulfilling all certification requirements.” He added: “This certification distinguishes Mediclinic Airport Road Hospital as a provider of heart attack services of the highest standards and this new certification is confirmation of the patient-centred quality care provided to our patients.”
The cardiac program focuses on reducing time of cardiac catheterisation, ensuring that all evidence-based treatment is provided in a timely manner while educating patients about their condition throughout their hospital stay.”
The Acute Coronary Syndrome program is operated by a multidisciplinary team consisting of highly trained interventional cardiologists, cardiac surgeons, a dedicated catheterisation laboratory nursing team, and highly qualified experts representing the various areas involved in providing safe and ethical care.
Dr. Mohammed Andron, Consultant Interventional Cardiologist, Head of Cardiology and Cardiac Catheterisation Unit at Mediclinic Airport Road Hospital said: “The program follows the most up-to-date international standards to ascertain that our patients are receiving appropriate quality treatments, may it be surgical or non-surgical.” He added: “Our centre is equipped with advanced instruments and technological innovation, enabling us to perform various types of cardiac procedures with excellent outcomes.”
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
